Quidel PE Ratio 2006-2019 | QDEL

Current and historical p/e ratio for Quidel (QDEL) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Quidel PE ratio as of May 21, 2019 is 23.09.
Quidel PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-05-21 55.88 57.61
2019-03-31 65.47 $0.97 67.49
2018-12-31 48.82 $1.83 26.68
2018-09-30 65.17 $0.90 72.41
2018-06-30 66.50 $0.47 141.49
2018-03-31 51.81 $0.20 259.05
2017-12-31 43.35 $-0.24 0.00
2017-09-30 43.86 $-0.15 0.00
2017-06-30 27.14 $-0.01 0.00
2017-03-31 22.64 $0.10 226.40
2016-12-31 21.42 $-0.43 0.00
2016-09-30 22.09 $-0.38 0.00
2016-06-30 17.86 $-0.38 0.00
2016-03-31 17.26 $-0.40 0.00
2015-12-31 21.20 $-0.18 0.00
2015-09-30 18.88 $0.03 629.33
2015-06-30 22.95 $-0.12 0.00
2015-03-31 26.98 $-0.06 0.00
2014-12-31 28.92 $-0.21 0.00
2014-09-30 26.87 $-0.38 0.00
2014-06-30 22.11 $-0.34 0.00
2014-03-31 27.30 $-0.19 0.00
2013-12-31 30.89 $0.21 147.10
2013-09-30 28.40 $0.44 64.55
2013-06-30 25.53 $0.55 46.42
2013-03-31 23.75 $0.50 47.50
2012-12-31 18.67 $0.14 133.36
2012-09-30 18.93 $-0.09 0.00
2012-06-30 15.68 $-0.10 0.00
2012-03-31 18.37 $-0.11 0.00
2011-12-31 15.13 $0.24 63.04
2011-09-30 16.37 $0.20 81.85
2011-06-30 15.15 $0.02 757.50
2011-03-31 11.96 $0.04 299.00
2010-12-31 14.45 $-0.40 0.00
2010-09-30 10.99 $0.28 39.25
2010-06-30 12.69 $0.99 12.82
2010-03-31 14.54 $1.10 13.22
2009-12-31 13.78 $1.10 12.53
2009-09-30 16.23 $0.62 26.18
2009-06-30 14.56 $0.27 53.93
2009-03-31 9.22 $0.23 40.09
2008-12-31 13.07 $0.58 22.53
2008-09-30 16.41 $0.64 25.64
2008-06-30 16.54 $0.56 29.54
2008-03-31 16.06 $0.53 30.30
2007-12-31 19.47 $0.41 47.49
2007-09-30 19.56 $0.70 27.94
2007-06-30 17.56 $0.69 25.45
2007-03-31 12.00 $0.62 19.35
2006-12-31 13.62 $0.63 21.62
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.225B $0.522B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $134.131B 26.04
Medtronic (MDT) Ireland $117.713B 17.21
Stryker (SYK) United States $69.192B 24.69
Boston Scientific (BSX) United States $52.428B 25.13
Baxter (BAX) United States $38.416B 24.21
Zimmer Biomet Holdings (ZBH) United States $23.779B 15.28
Smith & Nephew SNATS (SNN) United Kingdom $18.325B 0.00
ResMed (RMD) United States $16.130B 30.82
Canopy Growth (CGC) Canada $15.483B 0.00
Aurora Cannabis (ACB) Canada $8.782B 86.60
Bio-Rad Laboratories (BIO) United States $8.771B 46.50
Perrigo (PRGO) Ireland $6.771B 11.45
Hill-Rom Holdings (HRC) United States $6.428B 19.49
Insulet (PODD) United States $6.250B 455.39
GW Pharmaceuticals (GWPH) United Kingdom $5.550B 0.00
Haemonetics (HAE) United States $5.160B 42.33
ICU Medical (ICUI) United States $4.655B 27.78
Hutchison China MediTech (HCM) China $3.566B 0.00
NuVasive (NUVA) United States $3.229B 26.37
Neogen (NEOG) United States $3.055B 49.67
Agios Pharmaceuticals (AGIO) United States $3.015B 0.00
National Vision Holdings (EYE) United States $2.148B 45.77
Aphria (APHA) $1.712B 0.00
HEXO (HEXO) $1.478B 0.00
Cardiovascular Systems (CSII) United States $1.382B 793.40
Phibro Animal Health (PAHC) United States $1.185B 17.76
AtriCure (ATRC) United States $1.153B 0.00
VAREX IMAGING (VREX) United States $1.091B 23.15
Lantheus Holdings (LNTH) United States $0.960B 25.50
NanoString Technologies (NSTG) United States $0.945B 0.00
Omeros (OMER) United States $0.931B 0.00
MacroGenics (MGNX) United States $0.915B 0.00
PetIQ (PETQ) United States $0.834B 20.25
Eagle Pharmaceuticals (EGRX) United States $0.773B 21.69
Cerus (CERS) United States $0.733B 0.00
TG Therapeutics (TGTX) United States $0.616B 0.00
Surmodics (SRDX) United States $0.528B 76.71
OraSure Technologies (OSUR) United States $0.526B 24.20
LeMaitre Vascular (LMAT) United States $0.523B 25.33
Quanterix (QTRX) United States $0.513B 0.00
Meridian Bioscience (VIVO) United States $0.480B 14.68
Evolus (EOLS) United States $0.479B 0.00
BioLife Solutions (BLFS) United States $0.346B 108.18
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Utah Medical Products (UTMD) United States $0.304B 21.06
Vapotherm (VAPO) United States $0.284B 0.00
Rockwell Medical (RMTI) United States $0.280B 0.00
Zynex (ZYXI) United States $0.255B 26.37
Owens & Minor (OMI) United States $0.232B 4.91
Cytosorbents (CTSO) United States $0.224B 0.00
Bovie Medical (APYX) United States $0.201B 0.00
Chimerix (CMRX) United States $0.179B 0.00
Fonar (FONR) United States $0.134B 7.07
Chembio Diagnostics (CEMI) United States $0.129B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
Female Health (VERU) United States $0.105B 0.00
InfuSystems Holdings (INFU) United States $0.095B 0.00
United-Guardian (UG) United States $0.094B 20.71
Neurotrope (NTRP) United States $0.093B 0.00
Insys Therapeutics (INSY) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 20.25
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.028B 0.00
BRAINSWAY LTD (BWAY) Israel $0.027B 0.00
Valeritas Holdings (VLRX) United States $0.020B 0.00
Myomo (MYO) United States $0.017B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 4.57